A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Clinical trial NCT05646381 · RECRUITING

Trial details

NCT number: NCT05646381
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Aortic Stenosis

Start date: 2024-03-07
Primary completion: 2030-03-12
Enrollment: 502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.